Advertisement

Why Are U.S. Girls Getting Meningococcal But Not Human Papilloma Virus Vaccines? Comparison of Factors Associated with Human Papilloma Virus and Meningococcal Vaccination Among Adolescent Girls 2008 to 2012

      Abstract

      Background

      Human papilloma virus (HPV) vaccination rates in the United States remain low, compared with other recommended adolescent vaccines. We compared factors associated with intention to receive and receipt of HPV and meningococcal vaccines and completion of the HPV vaccine series among U.S. adolescent girls.

      Methods

      Secondary analysis of data from the National Immunization Survey-Teen for 2008 through 2012 was performed. Multivariable logistic modeling was used to determine factors associated with intent to receive and receipt of HPV and meningococcal vaccination, completion of the HPV vaccine series among girls who started the series, and receipt of HPV vaccination among girls who received meningococcal vaccination.

      Findings

      Provider recommendation increased the odds of receipt and intention to receive both HPV and meningococcal vaccines. Provider recommendation was also associated with a three-fold increase in HPV vaccination among girls who received meningococcal vaccination (p < .001), indicating a relationship between provider recommendation and missed vaccine opportunities. However, White girls were 10% more likely to report provider recommendation than Black or Hispanic girls (p < .01), yet did not have higher vaccination rates, implying a role for parental refusal. No factors predicted consistently the completion of the HPV vaccine series among those who started.

      Conclusion

      Improving provider recommendation for co-administration of HPV and meningococcal vaccines would reduce missed opportunities for initiating the HPV vaccine series. However, different interventions may be necessary to improve series completion.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Women's Health Issues
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Advisory Committee on Immunization Practices (ACIP)
        Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices.
        MMWR Morbidity and Mortality Weekly Report. 2007; 56: 1-24
        • Advisory Committee on Immunization Practices (ACIP)
        FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
        MMWR Morbidity and Mortality Weekly Report. 2010; 59: 626-629
        • Bartlett J.A.
        • Peterson J.A.
        The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature.
        Journal of School Nursing. 2011; 27: 434-446
        • Bloom R.
        Insights on why some girls are skirting the HPV vaccine.
        2013 (Available:) (Accessed October 16, 2013)
        • Boom J.A.
        • Nelson C.S.
        • Laufman L.E.
        • Kohrt A.E.
        • Kozinetz C.A.
        Improvement in provider immunization knowledge and behaviors following a peer education intervention.
        Clinical Pediatrics. 2007; 46: 706-717
        • Brawner B.M.
        • Baker J.L.
        • Voytek C.D.
        • Leader A.
        • Cashman R.R.
        • Silverman R.
        • et al.
        The development of a culturally relevant, theoretically driven HPV prevention intervention for urban adolescent females and their parents/guardians.
        Health Promotion Practice. 2012; 14: 624-636
        • Brobeck E.
        • Bergh H.
        • Odencrants S.
        • Hildingh C.
        Primary healthcare nurses' experiences with motivational interviewing in health promotion practice.
        Journal of Clinical Nursing. 2011; 20: 3322-3330
        • Centers for Disease Control and Prevention (CDC)
        Vaccines for Children Program.
        2012 (Available:) (Accessed December 10, 2012)
        • Centers for Disease Control and Prevention (CDC)
        National and state vaccination coverage among adolescents aged 13-17 years–United States, 2011.
        MMWR Morbidity and Mortality Weekly Report. 2012; 61: 671-677
        • Centers for Disease Control and Prevention (CDC)
        National Immunization Survey-Teen: A user's guide for the 2011 Public-Use Data File.
        2012 (Available: ftp://ftp.cdc.gov/pub/health_statistics/nchs/dataset_documentation/nis/nisteenpuf11_dug.pdf. Accessed March 14, 2015.)
        • Centers for Disease Control and Prevention (CDC)
        Human papillomavirus-associated cancers - United States, 2004-2008.
        MMWR Morbidity and Mortality Weekly Report. 2012; 61: 258-261
        • Centers for Disease Control and Prevention (CDC)
        National and state vaccination coverage among adolescents aged 13-17 years - United States, 2012.
        MMWR Morbidity and Mortality Weekly Report. 2013; 62: 685-693
        • Centers for Disease Control and Prevention (CDC)
        Datasets for the National Immunization Survey - Teen.
        2013 (Available: http://www.cdc.gov/nchs/nis/data_files_teen.htm. Accessed March 14, 2013.)
        • Chaturvedi A.K.
        • Engels E.A.
        • Pfeiffer R.M.
        • Hernandez B.Y.
        • Xiao W.
        • Kim E.
        • et al.
        Human papillomavirus and rising oropharyngeal cancer incidence in the United States.
        Journal of Clinical Oncology. 2010; 29: 4294-4301
        • Clifford G.
        • Franceschi S.
        • Diaz M.
        • Muñoz N.
        • Villa L.L.
        Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases.
        Vaccine. 2006; 24: S26-S34
        • Community Preventive Services Task Force
        Increasing appropriate vaccination.
        2014 (Available:) (Accessed October 20, 2014)
        • Dobson S.R.
        • McNeil S.
        • Dionne M.
        • Dawar M.
        • Ogilvie G.
        • Krajden M.
        • et al.
        Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: A randomized clinical trial.
        JAMA. 2013; 309: 1793-1802
        • Dorell C.
        • Yankey D.
        • Strasser S.
        Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey: Teen, 2009.
        Clinical Pediatrics. 2011; 50: 1116-1124
        • Dorell C.G.
        • Yankey D.
        • Santibanez T.A.
        • Markowitz L.E.
        Human papillomavirus vaccination series initiation and completion, 2008-2009.
        Pediatrics. 2011; 128: 830-839
        • Dunne E.F.
        • Unger E.R.
        • Sternberg M.
        • McQuillan G.
        • Swan D.C.
        • Patel S.S.
        • et al.
        Prevalence of HPV infection among females in the United States.
        JAMA. 2007; 297: 813-819
        • Elam-Evans L.D.
        • Yankey D.
        • Jeyarajah J.
        • Singleton J.A.
        • Curtis R.C.
        • MacNeil J.
        • et al.
        • Immunization Services Division, National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention (CDC)
        National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2013.
        MMWR Morbidity and Mortality Weekly Report. 2014; 63: 625-633
        • Gollust S.E.
        • Dempsey A.F.
        • Lantz P.M.
        • Ubel P.A.
        • Fowler E.F.
        Controversy undermines support for state mandates on the human papillomavirus vaccine.
        Health Affairs (Millwood). 2010; 29: 2041-2046
        • Greco P.J.
        • Eisenberg J.M.
        Changing physicians' practices.
        New England Journal of Medicine. 1993; 329: 1271-1273
        • Grulich A.E.
        • Jin F.
        • Conway E.L.
        • Stein A.N.
        • Hocking J.
        Cancers attributable to human papillomavirus infection.
        Sexual Health. 2010; 7: 244-252
        • Guerry S.L.
        • De Rosa C.J.
        • Markowitz L.E.
        • Walker S.
        • Liddon N.
        • Kerndt P.R.
        • et al.
        Human papillomavirus vaccine initiation among adolescent girls in high-risk communities.
        Vaccine. 2011; 29: 2235-2241
        • Haber G.
        • Malow R.M.
        • Zimet G.D.
        The HPV vaccine mandate controversy.
        Journal of Pediatric and Adolescent Gynecology. 2007; 20: 325-331
        • Heisler M.
        • Smith D.M.
        • Hayward R.A.
        • Krein S.L.
        • Kerr E.A.
        Racial disparities in diabetes care processes, outcomes, and treatment intensity.
        Medical Care. 2003; 41: 1221-1232
        • Hudson J.L.
        • Miller G.E.
        • Kirby J.B.
        Explaining racial and ethnic differences in children's use of stimulant medications.
        Medical Care. 2007; 45: 1068-1075
        • Jann B.
        The Blinder-Oaxaca decomposition for linear regression models.
        Stata Journal. 2008; 8: 453-479
        • Kempe A.
        • Barrow J.
        • Stokley S.
        • Saville A.
        • Glazner J.E.
        • Suh C.
        • et al.
        Effectiveness and cost of immunization recall at school-based health centers.
        Pediatrics. 2012; 129: e1446-e1452
        • Klein N.P.
        • Hansen J.
        • Chao C.
        • Velicer C.
        • Emery M.
        • Slezak J.
        • et al.
        Safety of quadrivalent human papillomavirus vaccine administered routinely to females.
        Archives of Pediatric and Adolescent Medicine. 2012; 166: 1140-1148
        • Kouyoumdjian F.G.
        • Bailowitz A.
        Completion of the human papillomavirus vaccine series in females attending an urban immunization clinic.
        Pediatric Infectious Disease Journal. 2011; 30: 718-719
        • Kressin N.R.
        • Petersen L.A.
        Racial differences in the use of invasive cardiovascular procedures: Review of the literature and prescription for future research.
        Annals of Internal Medicine. 2001; 135: 352-366
        • Lau M.
        • Lin H.
        • Flores G.
        Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health.
        Vaccine. 2012; 30: 3112-3118
        • Leib S.
        • Liberatos P.
        • Edwards K.
        Pediatricians' experience with and response to parental vaccine safety concerns and vaccine refusals: A survey of Connecticut pediatricians.
        Public Health Reports. 2011; 126: 13-23
        • Lindley M.C.
        • Smith P.J.
        • Rodewald L.E.
        Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009.
        Public Health Reports. 2011; 126: 124-134
        • Litton A.G.
        • Desmond R.A.
        • Gilliland J.
        • Huh W.K.
        • Franklin F.A.
        Factors associated with intention to vaccinate a daughter against HPV: A statewide survey in Alabama.
        Journal of Pediatric and Adolescent Gynecology. 2011; 24: 166-171
        • Markowitz L.E.
        • Hariri S.
        • Lin C.
        • Dunne E.F.
        • Steinau M.
        • McQuillan G.
        • et al.
        Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.
        Journal of Infectious Diseases. 2013; 208: 385-393
        • National Conference of State Legislatures (NCOSL)
        50 state summary of meningitis legislation and state laws.
        2012 (Available:) (Accessed October 1, 2013)
        • National Conference of State Legislatures (NCOSL)
        National Conference of State Legislatures HPV Vaccine: State legislation.
        2014 (Available:) (Accessed August 11, 2014)
        • Niccolai L.M.
        • Julian P.J.
        • Meek J.I.
        • McBride V.
        • Hadler J.L.
        • Sosa L.E.
        Declining rates of high-grade cervical lesions in young women in Connecticut, 2008-2011.
        Cancer Epidemiology, Biomarkers, & Prevention. 2013; 22: 1446-1450
        • Omer S.B.
        • Salmon D.A.
        • Orenstein W.A.
        • deHart M.P.
        • Halsey N.
        Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases.
        New England Journal of Medicine. 2009; 360: 1981-1988
        • Perkins R.B.
        • Anderson B.L.
        • Gorin S.S.
        • Schulkin J.A.
        Challenges in cervical cancer prevention: A survey of U.S. obstetrician-gynecologists.
        American Journal of Preventive Medicine. 2013; 45: 175-181
        • Perkins R.B.
        • Clark J.A.
        • Apte G.
        • Vercruysse J.L.
        • Sumner J.J.
        • Wall-Haas C.L.
        • et al.
        Missed opportunities for HPV vaccination in adolescent girls: A qualitative study.
        Pediatrics. 2014; 134: e666-e674
        • Phillips K.A.
        • Morrison K.R.
        • Andersen R.
        • Aday L.A.
        Understanding the context of healthcare utilization: Assessing environmental and provider-related variables in the behavioral model of utilization.
        Health Services Research. 1998; 33: 571-596
        • Presidents Cancer Panel
        President's Cancer Panel Annual Report 2012-2013: Accelerating HPV vaccine uptake: Urgency for action to prevent cancer.
        2014 (Available:) (Accessed February 24, 2014)
        • Saraiya M.
        • Rosser J.I.
        • Cooper C.P.
        Cancers that U.S. physicians believe the HPV vaccine prevents: Findings from a physician survey, 2009.
        Journal of Womens Health (Larchmont). 2012; 21: 111-117
        • Surveillance, Epidemiology, and End Results (SEER)
        SEER stat fact sheets: Cervix uteri cancer.
        2013 (Available:) (Accessed November 4, 2013)
        • Smith P.J.
        • Chu S.Y.
        • Barker L.E.
        Children who have received no vaccines: Who are they and where do they live?.
        Pediatrics. 2004; 114: 187-195
        • StataCorp
        Stata statistical software: Release 12.
        StataCorp LP, College Station, TX2012
        • Stokley S.
        • Jeyarajah J.
        • Yankey D.
        • Cano M.
        • Gee J.
        • Roark J.
        • et al.
        • Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC)
        Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States.
        MMWR Morbidity and Mortality Weekly Report. 2014; 63: 620-624
        • Suh C.A.
        • Saville A.
        • Daley M.F.
        • Glazner J.E.
        • Barrow J.
        • Stokley S.
        • et al.
        Effectiveness and net cost of reminder/recall for adolescent immunizations.
        Pediatrics. 2012; 129: e1437-e1445

      Biography

      Dr. Perkins is an obstetrician-gynecologist and researcher in HPV vaccination and cervical cancer prevention.

      Biography

      Ms. Lin is a biostatistics PhD candidate and programmer.

      Biography

      Dr. Silliman is a geriatrician and expert in women's health and health disparities.

      Biography

      Dr. Clark is a sociologist and researcher in adherence to medical recommendations.

      Biography

      Dr. Hanchate is a health economist and statistician and expert in large dataset analysis.